Literature DB >> 8088776

Structure and expression of the human GATA3 gene.

M C Labastie1, D Bories, C Chabret, J M Grégoire, S Chrétien, P H Roméo.   

Abstract

GATA3, a member of the GATA family that is abundantly expressed in the T-lymphocyte lineage, is thought to participate in T-cell receptor gene activation through binding to enhancers. To understand GATA3 gene regulation, we cloned the human gene and the 5' end of the mouse GATA3 gene. We show that the human GATA3 gene contains six exons distributed over 17 kb of DNA. The two human GATA3 zinc fingers are encoded by two separate exons highly conserved with those of GATA1, but no other structural homologies between these two genes can be found. The human and mouse GATA3 transcription units start at a major initiation site. The promoter sequence analysis of these two genes revealed that they are embedded within a CpG island and share structural features often found in the promoters of housekeeping genes. Finally, we show that a DNA fragment containing the human GATA3 transcription unit, 3 kb upstream from the initiation site and 4 kb downstream from the polyadenylation site, displays T-cell specificity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088776     DOI: 10.1006/geno.1994.1217

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  11 in total

1.  Hepatic to pancreatic switch defines a role for hemostatic factors in cellular plasticity in mice.

Authors:  Kumar Shanmukhappa; Reena Mourya; Gregg E Sabla; Jay L Degen; Jorge A Bezerra
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

2.  SOX10 and GATA3 in Adenoid Cystic Carcinoma and Polymorphous Adenocarcinoma.

Authors:  Brian D Adkins; Ariana Geromes; Lily Y Zhang; Rebecca Chernock; Katherine Kimmelshue; James Lewis; Kim Ely
Journal:  Head Neck Pathol       Date:  2019-06-20

3.  c-Myb regulates lineage choice in developing thymocytes via its target gene Gata3.

Authors:  Diane Maurice; Joel Hooper; Georgina Lang; Kathleen Weston
Journal:  EMBO J       Date:  2007-07-19       Impact factor: 11.598

4.  Novel dominant-negative mutant of GATA3 in HDR syndrome.

Authors:  Masaaki Ohta; Minenori Eguchi-Ishimae; Mayumi Ohshima; Hidehiko Iwabuki; Koji Takemoto; Kikuko Murao; Toshiyuki Chisaka; Eiichi Yamamoto; Takashi Higaki; Keiichi Isoyama; Mariko Eguchi; Eiichi Ishii
Journal:  J Mol Med (Berl)       Date:  2010-12-01       Impact factor: 4.599

5.  Isolation of a gene encoding a functional zinc finger protein homologous to erythroid Krüppel-like factor: identification of a new multigene family.

Authors:  K P Anderson; C B Kern; S C Crable; J B Lingrel
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

6.  Nuclear translocation of a maternal CCAAT factor at the start of gastrulation activates Xenopus GATA-2 transcription.

Authors:  A C Brewer; M J Guille; D J Fear; G A Partington; R K Patient
Journal:  EMBO J       Date:  1995-02-15       Impact factor: 11.598

7.  Hypoparathyroidism, sensorineural deafness, and renal dysgenesis syndrome with a GATA3 mutation.

Authors:  Yong Suk Shim; Woohyeok Choi; Il Tae Hwang; Seung Yang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-03-31

8.  A novel loss-of-function mutation of GATA3 (p.R299Q) in a Japanese family with Hypoparathyroidism, Deafness, and Renal Dysplasia (HDR) syndrome.

Authors:  Tetsuji Okawa; Masanori Yoshida; Takeshi Usui; Takahiro Kudou; Yasumasa Iwasaki; Kazuki Fukuoka; Norio Takahashi; Yuka Uehara; Yutaka Oiso
Journal:  BMC Endocr Disord       Date:  2015-10-30       Impact factor: 2.763

9.  Transactivation of human osteoprotegerin promoter by GATA-3.

Authors:  Shyan-Yuan Kao; Konstantina M Stankovic
Journal:  Sci Rep       Date:  2015-07-28       Impact factor: 4.379

10.  A Novel De Novo GATA Binding Protein 3 Mutation in a Turkish Boy with Hypoparathyroidism, Deafness, and Renal Dysplasia Syndrome.

Authors:  Gül Yeşiltepe Mutlu; Heves Kırmızıbekmez; Akie Nakamura; Maki Fukami; Şükrü Hatun
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.